NATURE OF BUSINESS AND ORGANIZATION (Details) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2024
USD ($)
|
Jun. 30, 2024
USD ($)
|
Mar. 31, 2024
USD ($)
|
Sep. 30, 2023
USD ($)
|
Jun. 30, 2023
USD ($)
|
Mar. 31, 2023
USD ($)
|
Sep. 30, 2022
USD ($)
|
Jun. 30, 2022
USD ($)
|
Mar. 31, 2022
USD ($)
|
Jun. 30, 2023
USD ($)
|
Jun. 30, 2022
USD ($)
|
Sep. 30, 2024
USD ($)
segment
|
Sep. 30, 2023
USD ($)
|
Sep. 30, 2022
USD ($)
|
Dec. 31, 2023
USD ($)
segment
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2024
USD ($)
|
|
| Accumulated deficit | $ 147,583,951 | $ 244,987,090 | $ 194,879,895 | $ 177,359,517 | $ 167,180,877 | $ 147,583,951 | $ 140,072,629 | $ 134,437,586 | $ 177,359,517 | $ 140,072,629 | $ 244,987,090 | $ 194,879,895 | $ 147,583,951 | $ 202,761,017 | $ 159,990,407 | |||
| Net loss | (14,664,719) | $ (919,371) | $ (26,641,983) | (17,520,378) | (10,178,640) | (7,190,470) | (7,511,322) | (5,635,043) | (6,239,797) | (17,369,110) | (11,874,840) | (42,226,073) | (34,889,488) | (19,386,162) | (42,770,610) | (31,792,618) | ||
| Unrestricted cash and cash equivalents | $ 17,785,322 | 34,263,371 | $ 18,986,443 | $ 5,152,972 | $ 12,682,691 | $ 17,785,322 | $ 24,805,565 | $ 30,634,122 | $ 5,152,972 | $ 24,805,565 | $ 34,263,371 | 18,986,443 | $ 17,785,322 | $ 9,564,988 | 19,866,358 | |||
| Number of Reportable Segments | segment | 1 | 1 | ||||||||||||||||
| Fixed asset impairment charges | $ 0 | 0 | $ 0 | 0 | ||||||||||||||
| Uninsured cash balances | 33,814,000 | $ 33,814,000 | 9,123,000 | |||||||||||||||
| Government Assistance, Income, Increase (Decrease), Statement of Income or Comprehensive Income [Extensible Enumeration] | Costs and Expenses | Costs and Expenses | ||||||||||||||||
| Reduction in research and development | $ 1,759,000 | |||||||||||||||||
| Subsequent event | ||||||||||||||||||
| Unrestricted cash and cash equivalents | $ 28,600,000 | |||||||||||||||||
| Cancer treatment research award through the National Cancer Institute (NCI) | ||||||||||||||||||
| Government Assistance Amount Cumulative | $ 2,000,000 | $ 2,000,000 | ||||||||||||||||
| Government Assistance Transaction Duration | 3 years | |||||||||||||||||
| Grant received | $ 1,980,000 | |||||||||||||||||
| Reduction in research and development | $ 602,000 | $ 1,314,000 | $ 697,000 | |||||||||||||||
| Leasehold improvements | ||||||||||||||||||
| Property and equipment useful lives | 64 months | 64 months | 64 months | |||||||||||||||
| Minimum | ||||||||||||||||||
| Property and equipment useful lives | 3 years | 3 years | 3 years | |||||||||||||||
| Share-based compensation expiration period | 12 months | 12 months | 12 months | |||||||||||||||
| Maximum | ||||||||||||||||||
| Property and equipment useful lives | 10 years | 10 years | 10 years | |||||||||||||||
| Share-based compensation expiration period | 3 years | 3 years | 3 years | |||||||||||||||
| X | ||||||||||
- Definition Amount of proceeds from research and development. No definition available.
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in income from government assistance. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of asset from government assistance. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Indicates line item in statement of income or comprehensive income that includes increase (decrease) in income from government assistance. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Duration of government assistance transaction, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. No definition available.
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|